Page 3 - Juan Carlos Jaen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Juan carlos jaen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Juan Carlos Jaen Today - Breaking & Trending Today

12,736 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Bought by Hancock Whitney Corp

Hancock Whitney Corp purchased a new stake in Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,736 shares of the company’s stock, valued at approximately $263,000. Several other hedge funds and other institutional investors also […] ....

Juan Carlos Jaen , Terryj Rosen , Jennifer Jarrett , Lazard Asset Management , Hancock Whitney Corp , Exchange Commission , Securities Exchange Commission , Hermes Inc , Arcus Biosciences Inc , Hm Payson Co , Arcus Biosciences , Get Rating , Financial Advisors , Asset Management , Inspire Investing , Arcus Biosciences Daily , Nyse Rcus , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Arcus Biosciences (NYSE:RCUS) Shares Up 5%

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) rose 5% during mid-day trading on Friday . The company traded as high as $18.34 and last traded at $18.33. Approximately 37,462 shares changed hands during trading, a decline of 97% from the average daily volume of 1,090,225 shares. The stock had previously closed at $17.46. […] ....

United States , Terryj Rosen , Jennifer Jarrett , Juan Carlos Jaen , Kiwi Wealth Investments Limited Partnership , Tennessee Treasury Department , Securities Exchange Commission , Arcus Biosciences Inc , Voya Investment Management , Arcus Biosciences , Get Rating , Exchange Commission , Investment Management , Arcus Biosciences Daily , Nyse Rcus ,

Arcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price […] ....

Terryj Rosen , Jennifer Jarrett , Juan Carlos Jaen , Hermes Inc , Hm Payson Co , Securities Exchange Commission , Arcus Biosciences Inc , Arcus Biosciences , Get Rating , Exchange Commission , Financial Advisors , Arcus Biosciences Daily , Nyse Rcus ,

Godsey & Gibb Inc. Purchases New Position in Vanguard S&P 500 ETF (NYSEARCA:VOO)

Should You Buy or Sell Arcus Biosciences Stock? Get The Latest RCUS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ....

United States , Terryj Rosen , Jennifer Jarrett , Juan Carlos Jaen , Securities Exchange Commission , Tennessee Treasury Department , Arcus Biosciences Inc , Voya Investment Management , Kiwi Wealth Investments Limited Partnership , Arcus Biosciences , Get Rating , Exchange Commission , Investment Management , Arcus Biosciences Daily ,

Arcus Biosciences (NYSE:RCUS) Raised to C at TheStreet

TheStreet upgraded shares of Arcus Biosciences (NYSE:RCUS – Get Rating) from a d rating to a c rating in a research note published on Monday, TheStreetRatingsTable reports. A number of other analysts have also commented on the stock. Truist Financial upped their price objective on shares of Arcus Biosciences from $70.00 to $77.00 in a […] ....

Jennifer Jarrett , Terryj Rosen , Juan Carlos Jaen , Securities Exchange Commission , Goldman Sachs Group Inc , Zacks Investment Research , Arcus Biosciences Inc , Arcus Biosciences Company Profile Get Rating , Wells Fargo Company , Goldman Sachs Group , Barclays Plc , Arcus Biosciences , Get Rating , Exchange Commission , Sachs Group , Biosciences Company Profile , Nyse Rcus ,